The company announced last month that Israeli patient monitoring startup Clair Labs raised $9 million in seed funding.
The Israeli venture capital company 10D led the investment, and SleepScore Ventures, Maniv Mobility and Vasuki participated in the investment.
Clair Labs has developed a proprietary technology to track the non-contact health of patients by monitoring physiological indicators (such as heart rate, respiration, airflow, body temperature, and oxygen saturation) and behavior indicators (such as sleep patterns and pain levels). After the sensor collects the data, the algorithm evaluates its meaning and reminds the patient or their caregiver.
Clair Labs said that the funds raised in this round will be used to recruit new employees for the company’s R&D center in Tel Aviv and open a new office in the United States, which will help provide better customer support and sales in North America.
Adi Berenson, Chief Executive Officer of Clair Labs, said: “The idea of Clair Labs began with the vision of forward-looking, preventive medicine, which requires health monitoring to be integrated into our lives before we become healthy.” “With the outbreak of the COVID-19 pandemic. , We realize how important effective and seamless monitoring is for nursing facilities as they are dealing with overwhelming patient capacity and increasing morbidity. Continuous and continuous patient monitoring will ensure early detection of deterioration or worrying Infection. It will help reduce adverse events, such as patient falls, pressure ulcers, etc. In the future, non-contact monitoring will enable remote monitoring of inpatient patients at home.”
Berenson co-founded the company in 2018 with CTO Ran Margolin. They met while working together on the Apple Product Incubation Team. Previously, Berenson served as the vice president of business development and marketing for PrimeSense, a pioneer in 3D sensing technology. From the early days, through cooperation with Microsoft, the Kinect motion sensing system was launched for Xbox, and then it was acquired by Apple. Dr. Margolin received his PhD in Technion , Is a computer vision and machine learning expert with extensive academic and industry experience, including his work in the Apple research team and Zoran algorithm team.
Their new enterprise will combine their skills and use new technologies to target the remote patient monitoring market. Currently, the company’s prototype is undergoing clinical trials in two Israeli hospitals: Tel Aviv Sourasky Medical Center at Ichilov Hospital and Assuta Sleep Medicine Institute at Assuta Hospital. They plan to start pilots in American hospitals and sleep centers later this year.
Dr. Ahuva Weiss-Meilik, head of the I-Medata AI Center at Sourasky Medical Center in Tel Aviv, said: “Currently, every patient in the internal medicine ward cannot perform continuous patient monitoring because of the limited capabilities of the medical team.” “It can help to monitor patients continuously. Technology that sends out intelligence and early warning when abnormal conditions are detected can improve the quality of care provided to patients.”
Post time: Jul-05-2021